At a glance
- Originator Terumo
- Class
- Mechanism of Action Ras gene inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 22 Nov 2007 Discontinued - Preclinical for Cancer in Japan (unspecified route)
- 07 Apr 2003 No development reported - Preclinical for Cancer in Japan (unspecified route)
- 12 Jan 2000 Preclinical development for Cancer in Japan (Unknown route)